Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Journal of Autoimmunity|April 15, 2005
Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosisYouri Chanseaud, Mathieu C Tamby, Philippe Guilpain, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 6, 2013
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNAMichelle Martinot-Peignoux, Martine Lapalus, Cédric Laouénan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
New therapies for hepatitis delta virus infectionDimitri Loureiro, Corinne Castelnau, Issam Tout, et al.Antiviral Therapy|December 25, 2009
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2aRami Moucari, Michelle Martinot-Peignoux, Vincent Mackiewicz, et al.Journal of Hepatology|January 16, 2007
High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapyRami Moucari, Marie-Pierre Ripault, Valérie Oulès, et al.Gastroenterology|November 28, 2002
Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis BVincent Di Martino, Thierry Thevenot, Jean-François Colin, et al.Hepatology (Baltimore, Md.)|August 31, 2006
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-upCorinne Castelnau, Frédéric Le Gal, Marie-Pierre Ripault, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 17, 2008
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibodySarah Maylin, Michelle Martinot-Peignoux, Marie-Pierre Ripault, et al.Hepatology (Baltimore, Md.)|May 21, 2014
Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis CLaure Elkrief, Pascale Chouinard, Noelle Bendersky, et al.Hepatology (Baltimore, Md.)|January 14, 2010
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirinMichelle Martinot-Peignoux, Christiane Stern, Sarah Maylin, et al.Pageof 5